Edwards Lifesciences (EW) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $86.95 +1.25%
EPS Growth %: +10.4%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +10.4%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.
GUIDANCE:
Edwards Lifesciences sees Q4 2023 revenue of $1.45-1.53 billion, versus the consensus of $1.54 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
